House committee approves $17.5M in new funding for tick-borne diseases

ByDorothy Leland
Lyme funding

From the Center for Lyme Action:

In good news, we are excited to announce that the House Appropriations Committee has approved the following increases for Lyme, alpha-gal, and other tick-borne diseases:

+$2M for CDC Vector-Borne Diseases (now 65.3M)

+$10M NIH Lyme and tickborne disease research setting the new minimum spend to $110M

+$0.5M CDC Lyme Disease (now $27.5M)

$5M LymeX to be managed by the HHS Office of the Chief Technology Officer

The House Appropriations Committee approved the Labor HHS Appropriations Bill on September 9 with a vote of 35-28. This bill is awaiting further action for a vote on the House floor, and we will keep you updated as we learn more.

Overall this is a wonderful result given the very difficult appropriations climate in Washington, D.C. Congratulations to all! This progress is a testament to our collective, persistent advocacy! If you would like to read the details, please see below.

Click here to learn more about the Center for Lyme Action.

  • DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS BILL, 2026 SEPTEMBER 9, 2025

    CDC EMERGING AND ZOONOTIC INFECTIOUS DISEASES
    Page 64

    CDC Alpha-gal 
    Page 64

    Page 65

    Page 66

    Also Page 66

    Page 67 – STARI

    NIH NIAID Alpha-Gal
    Page 64

    NIH NIAID Lyme and TBD
    Page 105 – 106

    Page 132

    ARPA-H
    Page 136

    Office of the Secretary – LymeX
    Page 199

    Page 203

    Office of the Secretary
    Page 212

Dorothy Leland is a longtime advocate and researcher focused on Lyme disease education, policy awareness, and patient support. She has contributed to numerous publications and works closely with medical professionals and organizations to improve understanding and treatment of tick-borne diseases.

Similar Posts